These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11106156)

  • 1. Nefazodone in the breast milk of nursing mothers: a report of two patients.
    Dodd S; Maguire KP; Burrows GD; Norman TR
    J Clin Psychopharmacol; 2000 Dec; 20(6):717-8. PubMed ID: 11106156
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine concentrations in breast milk and in maternal and infant sera.
    Arnold LM; Suckow RF; Lichtenstein PK
    J Clin Psychopharmacol; 2000 Aug; 20(4):491-3. PubMed ID: 10917415
    [No Abstract]   [Full Text] [Related]  

  • 3. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites.
    Yapp P; Ilett KF; Kristensen JH; Hackett LP; Paech MJ; Rampono J
    Ann Pharmacother; 2000 Nov; 34(11):1269-72. PubMed ID: 11098340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nefazodon (Nefadar)--a new dual serotoninergic antidepressant. Introductory press conference: "Nefazodone--new perspectives in antidepressive therapy." 25-26 April 1997].
    Fortschr Neurol Psychiatr; 1997 Oct; 65(10 Suppl Nefazodon):1-4. PubMed ID: 9390320
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to nefazodone in a depressed patient with end-stage renal disease.
    Seabolt JL; De León OA
    Gen Hosp Psychiatry; 2001; 23(1):45-6. PubMed ID: 11291641
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimates of nursing infant daily dose of fluoxetine through breast milk.
    Suri R; Stowe ZN; Hendrick V; Hostetter A; Widawski M; Altshuler LL
    Biol Psychiatry; 2002 Sep; 52(5):446-51. PubMed ID: 12242061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
    Mischoulon D; Dougherty DD; Bottonari KA; Gresham RL; Sonawalla SB; Fischman AJ; Fava M
    Psychiatry Res; 2002 Dec; 116(3):151-61. PubMed ID: 12477599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent.
    Campo JV; Smith C; Perel JM
    Arch Gen Psychiatry; 1998 Nov; 55(11):1050-2. PubMed ID: 9819077
    [No Abstract]   [Full Text] [Related]  

  • 9. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Rickels K; Schweizer E; Case WG; DeMartinis N; Greenblatt DJ; Mandos LA; Garcia España FG
    J Clin Psychopharmacol; 1998 Apr; 18(2):145-53. PubMed ID: 9580369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine and breast-feeding.
    Aichhorn W; Whitworth AB; Weiss U; Stuppaeck C
    Am J Psychiatry; 2004 Dec; 161(12):2325. PubMed ID: 15569912
    [No Abstract]   [Full Text] [Related]  

  • 11. Loratadine/nefazodone interaction.
    Barbey JT
    Clin Pharmacol Ther; 2002 May; 71(5):403; author reply 403. PubMed ID: 12011827
    [No Abstract]   [Full Text] [Related]  

  • 12. Nefazodone for the treatment of postpartum depression.
    Suri R; Burt VK; Altshuler LL
    Arch Womens Ment Health; 2005 May; 8(1):55-6. PubMed ID: 15868388
    [No Abstract]   [Full Text] [Related]  

  • 13. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk.
    Taddio A; Ito S; Koren G
    J Clin Pharmacol; 1996 Jan; 36(1):42-7. PubMed ID: 8932542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breast milk by high-performance liquid chromatography.
    Dodd S; Buist A; Burrows GD; Maguire KP; Norman TR
    J Chromatogr B Biomed Sci Appl; 1999 Jul; 730(2):249-55. PubMed ID: 10448960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1.
    Garton T
    Transplantation; 2002 Sep; 74(5):745. PubMed ID: 12352898
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid fade of antidepressant effect of nefazodone in bipolar depression.
    El-Mallakh RS
    J Clin Psychiatry; 1999 Aug; 60(8):559. PubMed ID: 10485645
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of dysphoric mania with nefazodone.
    Worthington JJ; Pollack MH
    Am J Psychiatry; 1996 May; 153(5):732-3. PubMed ID: 8615426
    [No Abstract]   [Full Text] [Related]  

  • 18. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Davis R; Whittington R; Bryson HM
    Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nefazodone and hypotension: complication or coincidence.
    D'Mello DA; Meland R; Ransom S
    J Clin Psychopharmacol; 1997 Apr; 17(2):136. PubMed ID: 10950489
    [No Abstract]   [Full Text] [Related]  

  • 20. Nefazodone for mood disorder associated with epilepsy.
    Balon R
    J Clin Psychiatry; 1998 Dec; 59(12):690. PubMed ID: 9921708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.